Viewing Study NCT04677959

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 2:42 PM

Ignite Modification Date: 2025-12-29 @ 5:39 PM

Study NCT ID: NCT04677959

Status: COMPLETED

Last Update Posted: 2023-03-14

First Post: 2020-12-11

Is Gene Therapy: True

Has Adverse Events: True

Brief Title: A 24-Week Treatment Study to Compare Standard of Care Versus the eMDPI DS in Participants 13 Years or Older With Asthma

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Adverse Events Module Baseline Characteristics Module Participant Flow Module